3-Part Ch. 11 Stalking Horse Sale OK'd For Teligent
Bankrupt generic pharmaceuticals venture Teligent Inc. secured a Delaware judge's approval Tuesday for a three-part stalking horse sale that could net the business $64 million or even more if other offers...To view the full article, register now.
Already a subscriber? Click here to view full article